Get notified when IVF files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Going Concern (new) — Both audit reports include a going-concern explanatory paragraph, indicating substantial doubt about the company's ability to continue operating.
- Nasdaq (new) — The company received Nasdaq delisting notices for late filings, indicating compliance issues.
- Reverse Stock Split (new) — A 1-for-5 reverse stock split was implemented, often a sign of a low stock price.
INVO Fertility registers 20M shares for resale by Alumni Capital; company may receive up to $15M from sales to Alumni
Filed August 7, 2026 · ~2 min read
Key Changes
-
high
This 424B3 registers up to 20,000,000 shares for resale by selling stockholder Alumni Capital LP; the company is not selling shares in this offering and receives no proceeds from Alumni's resales.
The Offering verify on EDGAR → -
high
Under a July 24, 2026 Purchase Agreement, INVO may sell up to $15 million of common stock to Alumni (up to $50 million by mutual agreement), with proceeds earmarked for clinic acquisitions, capex, working capital, and G&A.
Use of Proceeds verify on EDGAR → -
high
If all 20 million shares were issued, they would represent about 89.7% of outstanding shares, indicating massive potential dilution for existing holders.
Use of Proceeds verify on EDGAR →
3 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (PLAY 10-Q) is open in full — no account needed.
Partner
Trade IVF commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Figures/quotes linked to EDGAR · Narrative written by AI · Sep 1, 2026 · How we verify